{"id":814,"date":"2025-04-14T10:18:33","date_gmt":"2025-04-14T10:18:33","guid":{"rendered":"https:\/\/cpmiclinical.com\/?p=814"},"modified":"2025-04-15T15:13:12","modified_gmt":"2025-04-15T15:13:12","slug":"understanding-liver-impairment-clinical-trials","status":"publish","type":"post","link":"https:\/\/cpmiclinical.com\/es\/understanding-liver-impairment-clinical-trials\/","title":{"rendered":"Ensayos cl\u00ednicos sobre deterioro hep\u00e1tico: c\u00f3mo la investigaci\u00f3n impulsa las opciones de tratamiento"},"content":{"rendered":"
\"\"<\/figure>\n\n\n\n

Las enfermedades hep\u00e1ticas, incluyendo afecciones como la hepatitis esteat\u00f3tica asociada al metabolismo (MASH) y la cirrosis, son trastornos graves y, a menudo, progresivos que pueden afectar dr\u00e1sticamente la salud y la calidad de vida de una persona. Sin embargo, se est\u00e1n logrando avances significativos en el tratamiento de estas afecciones gracias a los ensayos cl\u00ednicos que trabajan para desarrollar terapias m\u00e1s eficaces. Al probar nuevos tratamientos, explorar los mecanismos subyacentes a la enfermedad hep\u00e1tica y profundizar en la comprensi\u00f3n del funcionamiento del h\u00edgado, los ensayos cl\u00ednicos est\u00e1n a la vanguardia para mejorar los resultados de las personas con insuficiencia hep\u00e1tica.<\/p>\n\n\n\n

En esta publicaci\u00f3n, exploraremos c\u00f3mo los ensayos cl\u00ednicos est\u00e1n desarrollando nuevos tratamientos para la enfermedad hep\u00e1tica, con especial atenci\u00f3n a la MASH, la cirrosis y otras formas de insuficiencia hep\u00e1tica. Adem\u00e1s, analizaremos qu\u00e9 implica la participaci\u00f3n en estos estudios y por qu\u00e9 es crucial para el avance de la atenci\u00f3n m\u00e9dica.<\/p>\n\n\n\n

El papel de los ensayos cl\u00ednicos en el tratamiento de las enfermedades hep\u00e1ticas<\/strong><\/p>\n\n\n\n

Las enfermedades hep\u00e1ticas como la esteatohepatitis no alcoh\u00f3lica (anteriormente conocida como esteatohepatitis no alcoh\u00f3lica o EHNA) y la cirrosis se caracterizan por inflamaci\u00f3n y da\u00f1o hep\u00e1tico que, si no se tratan, pueden eventualmente provocar insuficiencia hep\u00e1tica. Si bien existen tratamientos para algunas afecciones hep\u00e1ticas, muchos a\u00fan son limitados, y se necesitan nuevas terapias con urgencia.<\/p>\n\n\n\n

Los ensayos cl\u00ednicos son fundamentales para descubrir y probar nuevos tratamientos. Estos ensayos ayudan a los investigadores a comprender la seguridad, la eficacia y los posibles efectos secundarios de nuevos f\u00e1rmacos o terapias. Al incluir a una gama diversa de participantes, los ensayos cl\u00ednicos garantizan que los posibles tratamientos se prueben en diversas poblaciones, lo que resulta en opciones mejores y m\u00e1s universales.<\/p>\n\n\n\n

As\u00ed es como los ensayos cl\u00ednicos est\u00e1n haciendo avanzar el panorama del tratamiento de las enfermedades hep\u00e1ticas:<\/p>\n\n\n\n

1. Prueba de nuevos f\u00e1rmacos candidatos <\/strong><\/p>\n\n\n\n

Las compa\u00f1\u00edas farmac\u00e9uticas y los centros de investigaci\u00f3n desarrollan y prueban constantemente nuevos medicamentos para reducir la inflamaci\u00f3n, prevenir la fibrosis (cicatrizaci\u00f3n hep\u00e1tica) o incluso regenerar el tejido hep\u00e1tico. Los ensayos cl\u00ednicos ayudan a determinar si estos f\u00e1rmacos candidatos pueden ralentizar la progresi\u00f3n de la enfermedad hep\u00e1tica y mejorar la calidad de vida de los pacientes.<\/p>\n\n\n\n

2. Abordar las causas subyacentes de la enfermedad hep\u00e1tica <\/strong><\/p>\n\n\n\n

Durante a\u00f1os, los investigadores se han centrado en comprender las causas fundamentales de las enfermedades hep\u00e1ticas, incluyendo trastornos metab\u00f3licos como la obesidad, la diabetes y la hipertensi\u00f3n, que se relacionan con afecciones como el s\u00edndrome de MASH. Los ensayos cl\u00ednicos ayudan a descubrir los mecanismos que las impulsan, lo que permite el desarrollo de terapias dirigidas que abordan las causas directamente.<\/p>\n\n\n\n

3. Evaluaci\u00f3n de enfoques no farmacol\u00f3gicos<\/strong><\/p>\n\n\n\n

Los ensayos cl\u00ednicos tambi\u00e9n exploran intervenciones en el estilo de vida, como la dieta, el ejercicio y la p\u00e9rdida de peso. Estos enfoques son especialmente importantes para enfermedades como el s\u00edndrome de MASH, donde los cambios en el estilo de vida son fundamentales para el manejo de la enfermedad. Los ensayos cl\u00ednicos eval\u00faan si estas intervenciones no farmacol\u00f3gicas pueden mejorar la funci\u00f3n hep\u00e1tica y ralentizar la progresi\u00f3n de la enfermedad.<\/p>\n\n\n\n

4. Ampliaci\u00f3n de las opciones de tratamiento para la cirrosis <\/strong><\/p>\n\n\n\n

La cirrosis, una enfermedad hep\u00e1tica en etapa avanzada, hist\u00f3ricamente ha tenido opciones de tratamiento limitadas m\u00e1s all\u00e1 del manejo de las complicaciones. Sin embargo, los ensayos cl\u00ednicos ahora est\u00e1n investigando nuevas terapias que...<\/p>\n\n\n\n

Puede ayudar a regenerar las c\u00e9lulas hep\u00e1ticas o incluso detener la progresi\u00f3n de la insuficiencia hep\u00e1tica. La terapia con c\u00e9lulas madre y la terapia g\u00e9nica son dos \u00e1reas de investigaci\u00f3n prometedoras que muestran resultados prometedores en el tratamiento de la cirrosis.<\/p>\n\n\n\n

\"\"<\/figure>\n\n\n\n

C\u00f3mo es la participaci\u00f3n en un ensayo cl\u00ednico<\/strong><\/p>\n\n\n\n

Participar en un ensayo cl\u00ednico ofrece a los pacientes la oportunidad de acceder a tratamientos de vanguardia que quiz\u00e1s a\u00fan no est\u00e9n disponibles a trav\u00e9s de los canales de atenci\u00f3n m\u00e9dica tradicionales. Tambi\u00e9n puede ser una forma de contribuir al futuro del tratamiento de las enfermedades hep\u00e1ticas. Pero \u00bfqu\u00e9 implica realmente la participaci\u00f3n?<\/p>\n\n\n\n

1. Evaluaci\u00f3n y elegibilidad <\/strong><\/p>\n\n\n\n

Antes de unirse a un ensayo cl\u00ednico, los participantes se someten a un exhaustivo proceso de selecci\u00f3n para determinar si cumplen los criterios del estudio. Esto puede incluir pruebas para evaluar la funci\u00f3n hep\u00e1tica, estudios de imagen y una revisi\u00f3n del historial m\u00e9dico. Los criterios de elegibilidad var\u00edan seg\u00fan el tipo de enfermedad hep\u00e1tica en estudio, por lo que no todos cumplen los requisitos.<\/p>\n\n\n\n

2. Consentimiento informado<\/strong><\/p>\n\n\n\n

Todos los posibles participantes deben dar su consentimiento informado, lo que significa que est\u00e1n plenamente informados sobre los objetivos, procedimientos, posibles riesgos y beneficios del estudio. Este paso garantiza que las personas comprendan sus derechos y su papel en el ensayo.<\/p>\n\n\n\n

3. Procedimientos del Juicio Participantes<\/strong><\/p>\n\n\n\n

En ensayos cl\u00ednicos, los pacientes pueden recibir el f\u00e1rmaco experimental, un placebo (en algunos casos) o un tratamiento est\u00e1ndar como parte del estudio. Tambi\u00e9n pueden someterse a un seguimiento regular, que puede incluir an\u00e1lisis de sangre, im\u00e1genes, biopsias y otros procedimientos. Estos pasos permiten a los investigadores monitorear los efectos del f\u00e1rmaco en el h\u00edgado y la salud general.<\/p>\n\n\n\n

4. Posibles riesgos y beneficios<\/strong><\/p>\n\n\n\n

Como cualquier procedimiento m\u00e9dico, participar en un ensayo cl\u00ednico conlleva ciertos riesgos. Los nuevos tratamientos podr\u00edan tener efectos secundarios inesperados o podr\u00edan no ser tan eficaces como...<\/p>","protected":false},"excerpt":{"rendered":"

Las enfermedades hep\u00e1ticas, incluyendo afecciones como la hepatitis esteat\u00f3tica asociada al metabolismo (MASH) y la cirrosis, son trastornos graves y, a menudo, progresivos que pueden afectar dr\u00e1sticamente la salud y la calidad de vida de una persona. Sin embargo, se est\u00e1n logrando avances significativos en el tratamiento de estas afecciones gracias a ensayos cl\u00ednicos que buscan desarrollar terapias m\u00e1s eficaces. Al probar\u2026 <\/p>\n

Lee mas<\/a><\/p>","protected":false},"author":9,"featured_media":816,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[42],"tags":[57,69,60,78,64],"class_list":["post-814","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized-en","tag-blog","tag-clinical-research","tag-clinical-trials","tag-liver-disease","tag-liver-health","generate-columns","tablet-grid-50","mobile-grid-100","grid-parent","grid-50"],"yoast_head":"\nUnderstanding Liver Impairment Clinical Trials: How Research Is Advancing Treatment Options - Clinical Pharmacology of Miami<\/title>\n<meta name=\"description\" content=\"Liver diseases, including conditions like Metabolic Associated Steatotic Hepatitis (MASH) and cirrhosis, are serious and often progressive disorders that can dramatically impact a person's health and quality of life. However, significant progress is being made in the treatment of these conditions, thanks to clinical trials that are working to develop more effective therapies. By testing new treatments, exploring the mechanisms behind liver disease, and advancing our understanding of how the liver functions, clinical trials are at the forefront of improving outcomes for those affected by liver impairment.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cpmiclinical.com\/es\/understanding-liver-impairment-clinical-trials\/\" \/>\n<meta property=\"og:locale\" content=\"es_MX\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Understanding Liver Impairment Clinical Trials: How Research Is Advancing Treatment Options - Clinical Pharmacology of Miami\" \/>\n<meta property=\"og:description\" content=\"Liver diseases, including conditions like Metabolic Associated Steatotic Hepatitis (MASH) and cirrhosis, are serious and often progressive disorders that can dramatically impact a person's health and quality of life. However, significant progress is being made in the treatment of these conditions, thanks to clinical trials that are working to develop more effective therapies. By testing new treatments, exploring the mechanisms behind liver disease, and advancing our understanding of how the liver functions, clinical trials are at the forefront of improving outcomes for those affected by liver impairment.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cpmiclinical.com\/es\/understanding-liver-impairment-clinical-trials\/\" \/>\n<meta property=\"og:site_name\" content=\"Clinical Pharmacology of Miami\" \/>\n<meta property=\"article:published_time\" content=\"2025-04-14T10:18:33+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-04-15T15:13:12+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cpmiclinical.com\/wp-content\/uploads\/2025\/04\/Graphics_BMR-copy-4-1-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1344\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Dylan Bahe\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Dylan Bahe\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/cpmiclinical.com\\\/understanding-liver-impairment-clinical-trials\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/cpmiclinical.com\\\/understanding-liver-impairment-clinical-trials\\\/\"},\"author\":{\"name\":\"Dylan Bahe\",\"@id\":\"https:\\\/\\\/cpmiclinical.com\\\/#\\\/schema\\\/person\\\/1537d14f60060f10f99e58982bb18dad\"},\"headline\":\"Understanding Liver Impairment Clinical Trials: How Research Is Advancing Treatment Options\",\"datePublished\":\"2025-04-14T10:18:33+00:00\",\"dateModified\":\"2025-04-15T15:13:12+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/cpmiclinical.com\\\/understanding-liver-impairment-clinical-trials\\\/\"},\"wordCount\":720,\"publisher\":{\"@id\":\"https:\\\/\\\/cpmiclinical.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/cpmiclinical.com\\\/understanding-liver-impairment-clinical-trials\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cpmiclinical.com\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/Graphics_BMR-copy-4-1-scaled.jpg\",\"keywords\":[\"Blog\",\"Clinical Research\",\"Clinical trials\",\"Liver Disease\",\"liver health\"],\"articleSection\":[\"Uncategorized\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/cpmiclinical.com\\\/understanding-liver-impairment-clinical-trials\\\/\",\"url\":\"https:\\\/\\\/cpmiclinical.com\\\/understanding-liver-impairment-clinical-trials\\\/\",\"name\":\"Understanding Liver Impairment Clinical Trials: How Research Is Advancing Treatment Options - Clinical Pharmacology of Miami\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/cpmiclinical.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/cpmiclinical.com\\\/understanding-liver-impairment-clinical-trials\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/cpmiclinical.com\\\/understanding-liver-impairment-clinical-trials\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cpmiclinical.com\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/Graphics_BMR-copy-4-1-scaled.jpg\",\"datePublished\":\"2025-04-14T10:18:33+00:00\",\"dateModified\":\"2025-04-15T15:13:12+00:00\",\"description\":\"Liver diseases, including conditions like Metabolic Associated Steatotic Hepatitis (MASH) and cirrhosis, are serious and often progressive disorders that can dramatically impact a person's health and quality of life. However, significant progress is being made in the treatment of these conditions, thanks to clinical trials that are working to develop more effective therapies. By testing new treatments, exploring the mechanisms behind liver disease, and advancing our understanding of how the liver functions, clinical trials are at the forefront of improving outcomes for those affected by liver impairment.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/cpmiclinical.com\\\/understanding-liver-impairment-clinical-trials\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/cpmiclinical.com\\\/understanding-liver-impairment-clinical-trials\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/cpmiclinical.com\\\/understanding-liver-impairment-clinical-trials\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cpmiclinical.com\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/Graphics_BMR-copy-4-1-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/cpmiclinical.com\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/Graphics_BMR-copy-4-1-scaled.jpg\",\"width\":2560,\"height\":1344},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/cpmiclinical.com\\\/understanding-liver-impairment-clinical-trials\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/cpmiclinical.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Understanding Liver Impairment Clinical Trials: How Research Is Advancing Treatment Options\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/cpmiclinical.com\\\/#website\",\"url\":\"https:\\\/\\\/cpmiclinical.com\\\/\",\"name\":\"Clinical Pharmacology of Miami\",\"description\":\"Clinical research in Miami \\\/ Hialeah, FL\",\"publisher\":{\"@id\":\"https:\\\/\\\/cpmiclinical.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/cpmiclinical.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/cpmiclinical.com\\\/#organization\",\"name\":\"Clinical Pharmacology of Miami\",\"url\":\"https:\\\/\\\/cpmiclinical.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/cpmiclinical.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/cpmiclinical.com\\\/wp-content\\\/uploads\\\/2026\\\/02\\\/CPMI-Blue-Logo-copy.webp\",\"contentUrl\":\"https:\\\/\\\/cpmiclinical.com\\\/wp-content\\\/uploads\\\/2026\\\/02\\\/CPMI-Blue-Logo-copy.webp\",\"width\":150,\"height\":134,\"caption\":\"Clinical Pharmacology of Miami\"},\"image\":{\"@id\":\"https:\\\/\\\/cpmiclinical.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/cpmiclinical.com\\\/#\\\/schema\\\/person\\\/1537d14f60060f10f99e58982bb18dad\",\"name\":\"Dylan Bahe\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/0c1ae25cfb43c40e7dcb83bf283642be6020d8fa2a2836a7886c2d8ff6fb83f3?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/0c1ae25cfb43c40e7dcb83bf283642be6020d8fa2a2836a7886c2d8ff6fb83f3?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/0c1ae25cfb43c40e7dcb83bf283642be6020d8fa2a2836a7886c2d8ff6fb83f3?s=96&d=mm&r=g\",\"caption\":\"Dylan Bahe\"},\"url\":\"https:\\\/\\\/cpmiclinical.com\\\/es\\\/author\\\/dylanb\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Ensayos cl\u00ednicos sobre deterioro hep\u00e1tico: c\u00f3mo la investigaci\u00f3n impulsa las opciones de tratamiento - Farmacolog\u00eda Cl\u00ednica de Miami","description":"Las enfermedades hep\u00e1ticas, incluyendo afecciones como la hepatitis esteat\u00f3tica asociada al metabolismo (MASH) y la cirrosis, son trastornos graves y, a menudo, progresivos que pueden afectar dr\u00e1sticamente la salud y la calidad de vida de una persona. Sin embargo, se est\u00e1n logrando avances significativos en el tratamiento de estas afecciones gracias a los ensayos cl\u00ednicos que trabajan para desarrollar terapias m\u00e1s eficaces. Al probar nuevos tratamientos, explorar los mecanismos subyacentes a la enfermedad hep\u00e1tica y profundizar en la comprensi\u00f3n del funcionamiento del h\u00edgado, los ensayos cl\u00ednicos est\u00e1n a la vanguardia para mejorar los resultados de las personas con insuficiencia hep\u00e1tica.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cpmiclinical.com\/es\/understanding-liver-impairment-clinical-trials\/","og_locale":"es_MX","og_type":"article","og_title":"Understanding Liver Impairment Clinical Trials: How Research Is Advancing Treatment Options - Clinical Pharmacology of Miami","og_description":"Liver diseases, including conditions like Metabolic Associated Steatotic Hepatitis (MASH) and cirrhosis, are serious and often progressive disorders that can dramatically impact a person's health and quality of life. However, significant progress is being made in the treatment of these conditions, thanks to clinical trials that are working to develop more effective therapies. By testing new treatments, exploring the mechanisms behind liver disease, and advancing our understanding of how the liver functions, clinical trials are at the forefront of improving outcomes for those affected by liver impairment.","og_url":"https:\/\/cpmiclinical.com\/es\/understanding-liver-impairment-clinical-trials\/","og_site_name":"Clinical Pharmacology of Miami","article_published_time":"2025-04-14T10:18:33+00:00","article_modified_time":"2025-04-15T15:13:12+00:00","og_image":[{"width":2560,"height":1344,"url":"https:\/\/cpmiclinical.com\/wp-content\/uploads\/2025\/04\/Graphics_BMR-copy-4-1-scaled.jpg","type":"image\/jpeg"}],"author":"Dylan Bahe","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Dylan Bahe","Tiempo de lectura":"4 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cpmiclinical.com\/understanding-liver-impairment-clinical-trials\/#article","isPartOf":{"@id":"https:\/\/cpmiclinical.com\/understanding-liver-impairment-clinical-trials\/"},"author":{"name":"Dylan Bahe","@id":"https:\/\/cpmiclinical.com\/#\/schema\/person\/1537d14f60060f10f99e58982bb18dad"},"headline":"Understanding Liver Impairment Clinical Trials: How Research Is Advancing Treatment Options","datePublished":"2025-04-14T10:18:33+00:00","dateModified":"2025-04-15T15:13:12+00:00","mainEntityOfPage":{"@id":"https:\/\/cpmiclinical.com\/understanding-liver-impairment-clinical-trials\/"},"wordCount":720,"publisher":{"@id":"https:\/\/cpmiclinical.com\/#organization"},"image":{"@id":"https:\/\/cpmiclinical.com\/understanding-liver-impairment-clinical-trials\/#primaryimage"},"thumbnailUrl":"https:\/\/cpmiclinical.com\/wp-content\/uploads\/2025\/04\/Graphics_BMR-copy-4-1-scaled.jpg","keywords":["Blog","Clinical Research","Clinical trials","Liver Disease","liver health"],"articleSection":["Uncategorized"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/cpmiclinical.com\/understanding-liver-impairment-clinical-trials\/","url":"https:\/\/cpmiclinical.com\/understanding-liver-impairment-clinical-trials\/","name":"Ensayos cl\u00ednicos sobre deterioro hep\u00e1tico: c\u00f3mo la investigaci\u00f3n impulsa las opciones de tratamiento - Farmacolog\u00eda Cl\u00ednica de Miami","isPartOf":{"@id":"https:\/\/cpmiclinical.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cpmiclinical.com\/understanding-liver-impairment-clinical-trials\/#primaryimage"},"image":{"@id":"https:\/\/cpmiclinical.com\/understanding-liver-impairment-clinical-trials\/#primaryimage"},"thumbnailUrl":"https:\/\/cpmiclinical.com\/wp-content\/uploads\/2025\/04\/Graphics_BMR-copy-4-1-scaled.jpg","datePublished":"2025-04-14T10:18:33+00:00","dateModified":"2025-04-15T15:13:12+00:00","description":"Las enfermedades hep\u00e1ticas, incluyendo afecciones como la hepatitis esteat\u00f3tica asociada al metabolismo (MASH) y la cirrosis, son trastornos graves y, a menudo, progresivos que pueden afectar dr\u00e1sticamente la salud y la calidad de vida de una persona. Sin embargo, se est\u00e1n logrando avances significativos en el tratamiento de estas afecciones gracias a los ensayos cl\u00ednicos que trabajan para desarrollar terapias m\u00e1s eficaces. Al probar nuevos tratamientos, explorar los mecanismos subyacentes a la enfermedad hep\u00e1tica y profundizar en la comprensi\u00f3n del funcionamiento del h\u00edgado, los ensayos cl\u00ednicos est\u00e1n a la vanguardia para mejorar los resultados de las personas con insuficiencia hep\u00e1tica.","breadcrumb":{"@id":"https:\/\/cpmiclinical.com\/understanding-liver-impairment-clinical-trials\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cpmiclinical.com\/understanding-liver-impairment-clinical-trials\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/cpmiclinical.com\/understanding-liver-impairment-clinical-trials\/#primaryimage","url":"https:\/\/cpmiclinical.com\/wp-content\/uploads\/2025\/04\/Graphics_BMR-copy-4-1-scaled.jpg","contentUrl":"https:\/\/cpmiclinical.com\/wp-content\/uploads\/2025\/04\/Graphics_BMR-copy-4-1-scaled.jpg","width":2560,"height":1344},{"@type":"BreadcrumbList","@id":"https:\/\/cpmiclinical.com\/understanding-liver-impairment-clinical-trials\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cpmiclinical.com\/"},{"@type":"ListItem","position":2,"name":"Understanding Liver Impairment Clinical Trials: How Research Is Advancing Treatment Options"}]},{"@type":"WebSite","@id":"https:\/\/cpmiclinical.com\/#website","url":"https:\/\/cpmiclinical.com\/","name":"Clinical Pharmacology of Miami","description":"Investigaci\u00f3n cl\u00ednica en Miami \/ Hialeah, FL","publisher":{"@id":"https:\/\/cpmiclinical.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cpmiclinical.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/cpmiclinical.com\/#organization","name":"Clinical Pharmacology of Miami","url":"https:\/\/cpmiclinical.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/cpmiclinical.com\/#\/schema\/logo\/image\/","url":"https:\/\/cpmiclinical.com\/wp-content\/uploads\/2026\/02\/CPMI-Blue-Logo-copy.webp","contentUrl":"https:\/\/cpmiclinical.com\/wp-content\/uploads\/2026\/02\/CPMI-Blue-Logo-copy.webp","width":150,"height":134,"caption":"Clinical Pharmacology of Miami"},"image":{"@id":"https:\/\/cpmiclinical.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/cpmiclinical.com\/#\/schema\/person\/1537d14f60060f10f99e58982bb18dad","name":"Dylan Bahe","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/0c1ae25cfb43c40e7dcb83bf283642be6020d8fa2a2836a7886c2d8ff6fb83f3?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/0c1ae25cfb43c40e7dcb83bf283642be6020d8fa2a2836a7886c2d8ff6fb83f3?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/0c1ae25cfb43c40e7dcb83bf283642be6020d8fa2a2836a7886c2d8ff6fb83f3?s=96&d=mm&r=g","caption":"Dylan Bahe"},"url":"https:\/\/cpmiclinical.com\/es\/author\/dylanb\/"}]}},"_links":{"self":[{"href":"https:\/\/cpmiclinical.com\/es\/wp-json\/wp\/v2\/posts\/814","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cpmiclinical.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cpmiclinical.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cpmiclinical.com\/es\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/cpmiclinical.com\/es\/wp-json\/wp\/v2\/comments?post=814"}],"version-history":[{"count":0,"href":"https:\/\/cpmiclinical.com\/es\/wp-json\/wp\/v2\/posts\/814\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cpmiclinical.com\/es\/wp-json\/wp\/v2\/media\/816"}],"wp:attachment":[{"href":"https:\/\/cpmiclinical.com\/es\/wp-json\/wp\/v2\/media?parent=814"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cpmiclinical.com\/es\/wp-json\/wp\/v2\/categories?post=814"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cpmiclinical.com\/es\/wp-json\/wp\/v2\/tags?post=814"}],"curies":[{"name":"gracias","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}